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Ela¢n (also known as skin-derived anti-leukoprotei-
nase/trappin-2) is an epithelial host-defense protein that
is absent in normal skin but highly induced in keratino-
cytes of in£amed skin (e.g., psoriasis), in epidermal skin
tumors, and after wounding. Previously, it was shown
that in cultured keratinocytes, ela¢n expression is in-
duced by serum or tumor necrosis factor^a, and that
expression is suppressed by retinoids, dithranol, and
p38 mitogen-activated protein kinase inhibitors. Here
we have studied the regulation of ela¢n gene expression
in epidermal keratinocytes at the molecular level. First
we determined the transcription start site of the ela¢n
gene and found that the ela¢n mRNA possesses an unu-
sually short 50 -untranslated region. Using transient
transfection of luciferase reporter constructs of the ela-
¢n promoter, we mapped a 440 bp region upstream
of the translation start site that conferred high-level
expression in keratinocytes, but not in A431 cells or cells
of mesenchymal origin.We observed that the promoter
constructs were not subjected to the same regulation as
the endogenous ela¢n gene as these constructs were
highly active independent of keratinocyte stimulation.
When ela¢n promoter constructs were stably trans-
fected in the HaCaT keratinocyte cell line, tumor
necrosis factor-a inducible expression of both the endo-
genous ela¢n gene and the transgene was observed, sug-
gesting that regulation of the ela¢n gene is also
dependent on chromatin structure.We found, however,
that a stably transfected 4 kb ela¢n promoter fragment
did not confer retinoid sensitivity indicating that addi-
tional sequences are required for proper regulation.This
study reveals the complex regulation of a gene that can
be used as a paradigm for the speci¢c di¡erentiation
program of activated epidermal keratinocytes. Key
words: retinoids/TNF-alpha/transcription factors/psoriasis/
transfection. J Invest Dermatol 120:301 ^307, 2003
H
uman epidermis is mainly composed of keratino-
cytes, which follow a highly coordinated process
of terminal di¡erentiation. This normal epidermal
di¡erentiation pathway ultimately leads to the for-
mation of a protective layer of dead corneocytes
(Watt, 1989; Fuchs, 1990). There are, however, conditions such as
wounding and in£ammation, in which the epidermis follows an
alternative pathway. This pathway, which is characterized by hy-
perproliferation and distinct di¡erentiation, is a functional phy-
siologic response to conditions that require rapid epidermal
regeneration and protective gene expression.Yet a number of skin
conditions exist where this pathway seems inappropriate and is
part of a pathologic skin condition, such as psoriasis (McKay
and Leigh, 1995). There is not much known about the molecular
changes that are at the basis of this change in epidermal di¡eren-
tiation pathways. Insight into these earliest changes at the mole-
cular level could provide us with knowledge about the regulation
of epidermal di¡erentiation routes and could ultimately lead to
the identi¢cation of novel targets for the therapy of skin diseases.
A number of genes have been described previously, whose ex-
pression is induced or highly upregulated under the conditions
mentioned above.Well-known examples are the hyperprolifera-
tion-associated cytokeratins CK 6, 16, and 17 (Leigh et al, 1995).
Similar to the expression of CK 6, 16, and 17 (Navarro et al,
1995), the expression of the gene encoding ela¢n (also known as
skin-derived anti-leukoproteinase) is tightly correlated with ab-
normal epithelial di¡erentiation in a context of hyperprolifera-
tion. Ela¢n is highly expressed in keratinocytes of psoriatic
epidermis (Wiedow et al, 1990; Schalkwijk et al, 1993) and is indu-
cible in vivo by ultraviolet B irradiation (Pfundt et al, 2001), and
by tape stripping (a standardized model for epidermal injury and
transepidermal water loss) (Alkemade et al, 1992; Gerritsen et al,
1994).
By extrapolation, we hypothesize that knowledge on the mo-
lecular regulation of ela¢n expression could provide information
on the molecular regulation of the phenotype associated with ac-
tivated epidermis and its characteristic program of gene expres-
sion. In previous studies it has been shown that ela¢n gene
expression can be induced in vitro by stimulation of cultured un-
di¡erentiated primary keratinocytes with either fetal bovine ser-
um (FBS) or tumor necrosis factor (TNF)-a (Pfundt et al, 1996,
2000; van Ruissen et al, 1996). This in vitro induction of ela¢n
was shown to be dependent on the activity of the mitogen-acti-
vated protein kinase family member p38. In addition we showed
that ela¢n expression in vivo is induced by ultraviolet B irradia-
tion of normal human skin, is also correlated with p38 activation
(Pfundt et al, 2001). This led to the hypothesis that the expression
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of ela¢n is part of an epidermal stress response that is possibly
deregulated in pathologic skin conditions such as psoriasis.
Interestingly, ela¢n expression was found to be downregulated
by retinoids and by dithranol, which are known potent anti-psor-
iatics (Nagpal et al, 1996; Pol et al, 2002a).We therefore regard ela-
¢n expression as a surrogate marker for psoriasis.
So far, regulation of ela¢n gene expression at the molecular le-
vel has only been studied in nonkeratinocyte cells such as breast
epithelial and lung epithelial cell lines (Zhang et al, 1997; Bingle
et al, 2001). These studies, using transient transfections, have
revealed that transcription factor binding sites for alkaline
phosphatase-1 and nuclear factor (NF) kB in the ela¢n promoter
are important. Ela¢n expression and function in keratinocytes
has been studied in detail at the cellular level in vivo, but knowl-
edge of its molecular regulation is lacking. We have studied
regulation of the ela¢n gene in primary epidermal keratinocytes
and in the HaCaT keratinocyte cell line. An important observa-
tion from our studies is that, at least in keratinocytes, ela¢n
promoter activity cannot be simply inferred from transient trans-
fection studies, suggesting that other crucial regulatory
mechanisms exist.
MATERIALS AND METHODS
Chemicals All chemicals were obtained from Merck (Darmstadt,
Germany) with the exception of TNF-a (Boehringer, Mannheim,
Germany) and all-trans retinoic acid (RA) (Sigma, St Louis, MO). A 5
mM stock solution of RA was prepared in ethanol. Restriction enzymes
were from Boehringer. Primers were from Isogen (Amsterdam, the
Netherlands).
Cloning of the human ela¢n gene promoter region and reporter
gene constructs We have previously reported the cloning of a 9 kb
HindIII genomic fragment in pBluescript (Stratagene, La Jolla, CA),
which was shown to contain the human ela¢n gene (Molhuizen et al,
1994). This clone was designated pSKAG. From this clone an EcoRI/XbaI
fragment containing approximately 1 kb promoter region in addition to a
small part of the ¢rst exon was cloned in pBluescript KSþ resulting in
clone pSPRO29. Construct pSPRO29 was used as template in a PCR
reaction synthesizing the 1 kb promoter fragment (position ^1012/þ13;
all nucleotide positions in this paper are given relative to the start site of
translation; see Fig 1). Two primers [forward: 50 -GAATTCCCGGG
TTCATATAT-30, position ^1012/^993 (mutated nucleotide is underlined),
reverse: 50 -TGCTGGCCCCCATGGTGTCA, position 7/þ13) were
used to introduce a SmaI site and a NcoI at the 50 and the 30 site of the
polymerase chain reaction (PCR) product, respectively. The PCR product
was cloned in the pGEM-4 T-vector (Promega, Madison, WI) and
sequenced for veri¢cation. From this clone a 1 kb SmaI/NcoI fragment
(position 1004/þ 3) was directionally subcloned in frame with the ¢re£y
luciferase gene in pSla4, a modi¢ed pSla3 vector (van Dijk et al, 1991),
directly fused to the ATG of the luciferase gene through the NcoI site. The
resulting clone was designated pSPL1000. From this clone deletion mutants
were derived and designated pSPL440, pSPL290, pSPL170, and pSPL130.
All these constructs were prepared according to standard cloning
techniques using available restriction sites, except clone pSPL130. To
generate this clone we used a mutagenic forward primer (50 -
GTGGATATCTCCCAATAC-30, position 132/115) in a PCR reaction
with the previously mentioned reverse primer to introduce an EcoRV site
at position 126. From the resulting PCR product an EcoRV/NcoI
fragment was cloned in a SmaI/NcoI digested pSLA4 vector. The largest
transfection construct pSPL4500 was constructed via directional cloning
of an approximately 4 kb HindIII/BglII promoter fragment (position
4500/435) in a SmaI/BglII digested pSPL1000 construct. The two
promoter constructs pSPL1000intþ and pSPL1000int contain the entire
genomic sequence of the ela¢n gene in the correct and reverse
orientation, respectively. Both constructs containing the genomic ela¢n
sequence were made by directional cloning of a PCR product containing
the entire gene sequence (position þ 3/þ1631) in the KpnI site of construct
pSPL1000 between the stop codon and the ¢rst polyadenylation signal of
the luciferase gene. Finally, a construct containing the insert from clone
pSPL1000 in the reverse orientation, designated pSPL1000rev was
generated. To obtain this clone, the previously mentioned 1 kb SmaI/NcoI
fragment was used. A blunt end was generated at the NcoI site, and the
complete fragment was subcloned in the SmaI site from pSla4, thus
maintaining the original translation start codon from the luciferase gene.
Figure 2(A) gives a schematic representation of these nine constructs.
Determination of the ela¢n mRNA transcription start site using S1-
nuclease mapping S1 nuclease mapping using a single-stranded DNA
probe was used to determine the start site of transcription of the ela¢n
gene. To obtain a suitable DNA probe we cloned a BglII/XbaI fragment
(position 435 to þ 62) in pBluescript KSþ. Single-stranded DNA was
obtained by transforming the plasmid in Escherichia coli XL1-Blue cells
and infecting the transformed cells with M13K07 helper phage (as
described in Sambrook et al, 1989). To prepare the radiolabeled probe,
T7 primer (Promega) was annealed to 250 ng single-stranded DNA,
and primer extension was performed with 5 U of T7 DNA poly-
merase (Pharmacia, Uppsala, Sweden) in the presence of 0.5 mM
[a-32P]deoxycytidine triphosphate (3000 Ci per mmol; Amersham,
Buckinghamshire, U.K.), 0.4 mM deoxyadenosine triphosphate, 0.4 mM
deoxythymidine triphosphate, 0.4 mM deoxyguanosine triphosphate, and
1.3 mM deoxycytidine triphosphate (Amersham Biosciences, Uppsala,
Sweden). The radiolabeled fragment was separated from the template on a
4% polyacrylamide gel and isolated. Total RNA isolated from
keratinocytes grown in the presence of 5% FBS was used as a source for
ela¢n mRNA. Fifty micrograms of this total RNA was mixed with
8105 cpm single-stranded probe DNA. As a negative control yeast
tRNA (Boehringer) was used. The pellets were dissolved in 30 ml
hybridization bu¡er [40 mM PIPES (piperazine-N,N,-bis[2-ethanesulfonic
acid]) pH 8.0, 0.5 M NaCl, and 80% formamide] and incubated for 10 min
at 851C followed by an incubation for 16 h at 501C. After this probe
hybridization, 300 ml nuclease S1 reaction mix (280 mM NaCl, 5 mM
NaAc pH 4.5, 4.5 mM ZnSO4, 20 mg herring sperm DNA per ml
(Boehringer) and 1000 U per ml nuclease S1 (Amersham Biosciences) was
added and the reaction was incubated at 371C for 60 min. As a control
reaction to check for su⁄cient nuclease S1 activity, free radiolabeled probe
was subjected to nuclease S1 digestion. The samples were separated on an
Figure1. Nucleotide sequence of the human ela¢n gene promoter
region. Numbering is relative to the ¢rst base of the ATG translation co-
don (printed in bold). The borders of the fragments used for the luciferase
transfection constructs are indicated with arrows (+ ). The putative
‘‘CCAAT’’and ‘‘TATA’’ boxes are double underlined.The region of multiple
transcription start sites is underlined with a dotted line, the preferential
transcription start sites are printed in italics and bold. Consensus binding
sequences for known transcription factors are indicated by name and
underlined.
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8% polyacrylamide gel, and autoradiography was performed using Kodak
X-Omat 100 X-ray ¢lm.
Determination of ela¢n mRNA transcription start site using 50 -
RACE (rapid ampli¢cation of cDNA ends) RACE was used to
recon¢rm transcription start sites of endogenous ela¢n found with S1-
nuclease mapping in human keratinocytes. Using the 50/30 -RACE kit
(Boehringer) we performed 50 -RACE on 10 mg of total RNA isolated
from keratinocytes grown in keratinocyte growth medium (KGM)/FBS,
as suggested by the manufacturer. In the RACE reaction the ela¢n
speci¢c primers (SP) used were the primers SP1 (þ1013/þ1037), SP2
(þ 942/þ 966), and SP3 (þ 30/þ48). The produced RACE fragment was
puri¢ed on an agarose gel and cloned into the pGEM-Tvector (Promega).
The RACE clones obtained were sequenced by means of the dideoxy
chain termination method.
Cell culture Normal human keratinocytes were seeded in six well
culture dishes and cultured until con£uence in KGM as described before
(van Ruissen et al, 1994). At con£uence the cells were either transfected or
switched to one of the test media. Subsequently, the growth factors or
cytokines that were to be tested were added in di¡erent concentrations.
Induction of keratinocyte di¡erentiation was established by switching the
cells at con£uence either to KGM supplemented with 5% v/v FBS (KGM/
FBS) (FBS from Seralab, Nistelrode, the Netherlands) or to KGM depleted
of growth factors (Bovine Pituitary Extract, insulin, and epidermal growth
factor) and hydrocortisone (depleted of growth factors and hydro-
cortisone). Human skin ¢broblasts derived from healthy volunteers,
glioblastoma cells, and A431 cells were seeded and cultured in six well
culture dishes in A1 medium [Dulbecco minimal Eagle’s medium
(DMEM)/F12] (Flow Laboratories, Irvine, Scotland, U.K.) in a ratio of 3 :
1 supplemented with 100 U per ml penicillin, 100 mg streptomycin per ml
and 10% v/v (FBS).
Transient transfections Keratinocytes were transfected at con£uence.
Prior to transfection the cells were washed twice with 1 ml Keratinocyte
Basal Medium and 900 ml Keratinocyte Basal Medium was added.
Transfection mixes were made containing 0.75 pmol transfection
construct 0.5 pmol EF2-bGAL normalization construct (a kind gift from
Dr G. Swart, Department of Biochemistry, University of Nijmegen) and
25 ml lipidfection reagent (lipidfection reagent consisted of 0.8 mM di-
methyldioctadecylammonium bromide (Sigma), and 1.7 mM dioleoyl-L-a-
phosphatidylethanolamine (Sigma), prepared according to a method
described elsewhere (Carrol, 1994), in a ¢nal volume of 100 ml
Keratinocyte Basal Medium. These mixes were incubated for 20 min at
room temperature and the cells were transfected during 6 h. Twenty-four
hours after transfection the medium was aspirated and the cells were
switched either to KGM/FBS or to depleted of growth factors and
hydrocortisone, and incubated for another 24 h after which the cells were
harvested.
The human ¢broblasts, glioblastoma cells, and A431 cells were
transfected at 50^70% con£uence. Prior to transfection the cells were
washed twice with 1 ml DMEM/F12 (ratio 3:1) and 900 ml DMEM/F12
was added. Transfection mixes were made containing 1.3 pmol
transfection construct, 0.5 pmol EF2-bGAL and 25 ml DOSPER
(Boehringer) in a ¢nal volume of 100 ml DMEM/F12. These mixes were
incubated for 20 min at room temperature and added drop wise to the
cells. After 6 h of incubation 1 ml A1 medium was added to the cells.
Twenty-four hours after transfection the medium was aspirated and 2 ml
A1was added. After a ¢nal incubation of 24 h the cells were harvested.
Cell harvesting and reporter assays Transfected cells were washed
twice with phosphate-bu¡ered saline (NPBI, Emmer-Compascuum, the
Netherlands) and lyzed in 150 ml reporter lysis bu¡er (Promega).
Luciferase enzyme assay was performed with the Luciferase Assay System
(Promega) as suggested by the manufacturer using 10 ml cell lysate and
50 ml assay reagent. b-galactosidase enzyme assay was performed with the
‘‘Galacto-Light Plus’’ chemiluminescent reporter assay for the detection
of b-galactosidase (Tropix Inc., Bedford, MA) as suggested by the
manufacturer using 20 ml cell lysate. Promoter activities were measured as
the ratio between the luciferase activity and b-galactosidase activity per
sample.
Cell cultures of stably transfected HaCaT keratinocytes Previously,
we have generated two stably transfected keratinocyte cell lines (HaCaT) in
which, respectively, a 4 kb and a 0.8 kb fragment, derived from the
promoter of the ela¢n gene, drive the transcription of a gene fusion of
ela¢n and enhanced green £uorescent protein (EGFP) (Pol et al, 2002b).
The original clones designated ‘‘clone VI B3’’ and ‘‘clone 21’’ will
hereinafter be referred to as 4 kb ela¢nprom and 0.8 kb ela¢nprom. Cells
of these stable transfectants were seeded on to irradiated mouse 3T3
¢broblast feeder layers in 24-well tissue culture plates (Corning Costar,
Badhoevedorp, the Netherlands). Cultures were grown in DMEM with
4.5 g per liter glucose with L-glutamine (BioWhittaker Europe, Verviers,
Belgium) supplemented with 10% FBS (Harlan Seralab, Nistelrode, the
Netherlands) and penicillin (100 U per ml)/streptomycin (100 mg per ml)
(LifeTechnologies B.V., Breda, the Netherlands). Upon con£uence, cultures
were switched to medium with or without 25 ng TNF-a per ml.
Simultaneously, RA was added to the medium to create a dose range of
106, 107, and 108 M and cultures were maintained for another 72 h.
Culture supernatants were then collected and stored at 201C for later
analysis in enzyme-linked immunosorbent assay. Total RNA was isolated
and stored at 801C for northern blot analysis.
Northern blot analysis Total RNA was isolated from RA-treated
cultures of HaCaT clones 4 kb ela¢nprom and 0.8 kb ela¢nprom, 72 h
after con£uent cultures were switched to medium with or without TNF-
a. For isolation of total RNA we used TRIzol reagent according to
directions of the manufacturer (Life Technologies B.V.). Samples were
spectrophotometrically quantitated and equal amounts of 10 mg were
separated on an agarose gel. The samples were blotted on positively
charged nylon and subsequently used in hybridization experiments. The
ela¢n probe was obtained by generation of a 0.42 kb PvuII/EcoRI
fragment of the ela¢n cDNA clone pGESKA. The EGFP probe consisted
of a 0.76 kb NotI/PstI fragment of pEGFP-N1. Probes were 32P-labeled
using an oligo labeling kit (Amersham Biosciences). Autoradiography was
performed using Kodak X-OMAT X-ray ¢lms.
Analysis of secreted endogenous ela¢n Ela¢n levels were determined
in medium derived from HaCaT cultures by means of a sandwich-type
enzyme-linked immunosorbent assay, which is described elsewhere
(Vandermeeren et al, 2001). An ela¢n calibration curve (0.5^12.5 ng per
ml) was prepared from a stock of full-length ela¢n obtained by
Figure 2. Deletion mapping of the ela¢n promoter. (A) Schematic re-
presentation of the luciferase constructs containing deletion fragments of
the ela¢n promoter. Nucleotide positions are given relative to the transla-
tion start codon and indicate the orientation of the deletion fragment. (B)
Relative promoter activity of the various ela¢n promoter reporter con-
structs, de¢ned as the relative luciferase activity. The bars represent the re-
lative luciferase activity found in cell lysates of transient transfected
primary human keratinocytes cultured in either KGM/-GF or KGM/FCS.
Data are representative of three independent transfection experiments, and
reported as mean7 SEM.
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puri¢cation from cell culture supernatants. Concentrations of ela¢n were
read from this curve and expressed as ng secreted ela¢n per ml culture
medium.
Analysis of secreted ela¢n^EGFP fusion protein Ela¢n^EGFP
fusion protein concentrations were measured in medium derived from
HaCaT cultures using a sandwich-type enzyme-linked immunosorbent
assay as previously described (Pol et al, 2002b). Absorbance values for
untransfected HaCaT served as background level. Levels of ela¢n^EGFP
were expressed semiquantitatively as fold background.
RESULTS
The human ela¢n gene contains multiple transcription start
sites and the mRNA has an unusually short 50 -untranslated
region (50 -UTR) The cloning and partial structural
characterization of the ela¢n gene and cDNA has been described
previously (Saheki et al, 1992; Molhuizen et al, 1993, 1994). Based
upon the presence of consensus sequences for a TATA and
CCAAT box, the region directly 50 of the translation start site
was assigned as the putative promoter in previous studies by
others, although this has not been veri¢ed experimentally. We
initially used the S1-nuclease mapping technique to determine
the transcription start site of the ela¢n gene. Using this
technique, multiple transcription start sites were found from 9
to 24 bp upstream of the translation start site of the ela¢n gene
(not shown). As these positions would result in an unusually
short 50 -UTR, an independent method was used to con¢rm this
region as being the region where ela¢n transcription can start.
Application of the 50 -RACE technique also yielded short 50
fragments and con¢rmed the presence of multiple transcription
start sites; however, less size variation was found, as 60% of all
RACE clones were located around base residues 16/17/18
(Fig 3).
Deletion mapping of the ela¢n promoter In order to scan
the ela¢n promoter for sequences relevant for transcriptional
activity in human keratinocytes, a set of nine reporter constructs
(see Fig 2A) was designed covering approximately 4500 bp of
upstream and approximately 1600 bp of downstream gene
sequences. These constructs were transiently transfected in
human keratinocytes that were stimulated with FBS (see Fig
2B). Stepwise deletion of the region between 4500 and 440
did not a¡ect ela¢n promoter activity, as can be seen by the
relative luciferase activity of the transfection clones pSPL4500,
pSPL1000, and pSPL440. Based on the relative luciferase activity
of the transfection clones pSPL1000intþ and pSPL1000int,
containing the intron sequences of the ela¢n gene in both
orientations, it appears that the intron sequences do not have
any e¡ect on promoter activity in either orientation. Subsequent
deletion, however, of the region 440 and 290 (clone
pSPL290) resulted in a signi¢cant decrease of ela¢n promoter
activity in human keratinocytes of about 75%. Further deletion
of promoter sequences down to 170 bp 50 of the translation start
site (pSPL170) resulted in a decrease of promoter activity down to
10%. Transfection clone pSPL130, containing only minimal
promoter consensus binding sequences showed almost no
promoter activity in keratinocytes. Clone pSPL1000rev, in which
the upstream sequence of the ela¢n gene is cloned in reverse
orientation, resulted in a luciferase activity comparable with the
empty luciferase gene vector pSLA4. Figure 2B depicts the
activity of the promoter constructs transfected in keratinocytes
that were subsequently stimulated with FBS (KGM/FBS), which
is known to induce expression of the endogenous ela¢n gene
(van Ruissen et al, 1996).When the transfected cells were induced
to di¡erentiate by growth factor depletion of growth factors and
hydrocortisone, under which condition the endogenous ela¢n
gene is virtually silent compared with FBS stimulation, the
promoter constructs were still highly active (Fig 2B). This
discrepancy between the activity of the naked plasmid DNA
and the activity of the chromatin-embedded endogenous gene
suggest additional regulatory mechanisms for expression of the
endogenous gene, as will be discussed below.
The ela¢n promoter confers keratinocyte-speci¢c gene
expression To investigate whether the promoter region that
was investigated here could confer cell-type speci¢c expression,
reporter constructs were transfected in the epithelial A431 cell
line, primary human skin ¢broblasts, and the U138-MG
glioblastoma cell line. Figure 4 shows the relative activity of the
transfection clone pSPL1000 in the di¡erent cell types, compared
with the relative activity of the empty luciferase gene vector
pSLA4. As can be seen in Fig 4, the ela¢n promoter was highly
active in keratinocytes, whereas in ¢broblasts, glioblastoma cells,
and A431 cells hardly any transcriptional activity was found. This
e¡ect was also observed with other promoter constructs (data not
shown).
Regulation of stably transfected ela¢n promoter constructs
in HaCaTcells As described above, we observed a discrepancy
between the transcriptional regulation by the endogenous
ela¢n promoter and the regulation by promoter gene sequences
that were plasmid encoded. In order to gain insight in the regu-
latory mechanism underlying this divergence, we performed
Figure 3. Determination of the region where transcription of the
ela¢n gene initiates. Relative distribution of transcription start sites in
the ela¢n gene promoter determined by 50 -RACE. Nucleotide positions
(relative to the translation start site) are indicated on the X-axis. The graph
summarizes the results of 15 analyzed RACE clones.
Figure 4. Ela¢n promoter activity in di¡erent cell types. Primary
human keratinocytes, U138-MG glioblastoma cells, primary human skin
¢broblasts, and epithelial A431 cells were cotransfected with either empty
reporter construct pSLA4 and EF2-bGAL or with transfection clone
pSPL1000 and EF2-bGAL. Twenty-four hours after transfection cell cul-
tures received fresh medium containing either 10%FCS (glioblastoma, ¢-
broblast, epithelial A431) or 5%FCS (keratinocyte). After a ¢nal incubation
of 24 h, cells were harvested and assayed for luciferase enzyme activity. Va-
lues represent the promoter activity of pSPL1000 compared to that of
pSLA4 (assigned a value of 1).
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experiments using two di¡erent stably transfected HaCaT cell
lines harboring either a 0.8 kb or a 4 kb ela¢n promoter region,
which drives the transcription of an ela¢n^EGFP gene fusion.
The reason that in these constructs we used EGFP as a reporter
gene instead of luciferase is because these clones were generated
in a separate study to be used in a £uorescence-based high-
throughput screening system (Pol et al, 2002b). Northern blot
analysis using a probe directed against ela¢n demonstrated a
TNF-a dependent induction of both the endogenous ela¢n
mRNA and the ela¢n^EGFP speci¢c mRNA in either of the
clones (Fig 5). Note that discrepancies between basal
transcription levels of ela¢n among di¡erent clones derived
from the HaCaT cell line are a commonly observed
phenomenon (as discussed below). The ela¢n^EGFP transcript
was not detected in unstimulated cultures of these clones. In
addition, by using an EGFP-speci¢c probe we con¢rmed that
the ela¢n^EGFP mRNA is only present in the TNF-a-
stimulated cultures (results not shown). These results indicate
that the transgene is subjected to similar regulation as the
endogenous gene, following cell stimulation with TNF-a. To
investigate if the promoter construct contained all the necessary
information to respond to a pharmacologic modulator of ela¢n
expression, we used RA, a known inhibitor of ela¢n gene
expression (Nagpal et al, 1996; Lee et al, 1998) Addition of RA in
the dose range of 106, 107, and 108 M caused a concentration-
dependent decrease of endogenous ela¢n mRNA in both
unstimulated and TNF-a stimulated cultures.We found that RA
had no e¡ect on transcriptional regulation of ela¢n^EGFP as
witnessed by the mRNA levels, which remained unchanged
for all RA concentrations tested (see Fig 5). These observations
were con¢rmed at the protein level by data from two dif-
ferent enzyme-linked immunosorbent assays, one speci¢c for
endogenous ela¢n protein and the other one speci¢c for the
fusion protein transcribed from the transgene. Figure 6, parts
(A) and (B), show, respectively, the concentrations of endogenous
ela¢n and the relative levels of ela¢n^EGFP fusion protein in
culture medium of TNF-a stimulated cultures of the 0.8 kb
ela¢nprom clone. It was found that levels of ela¢n decreased
in a concentration-dependent way by increasing levels of
RA, whereas no e¡ect of RA was observed on the level of
ela¢n^EGFP fusion protein in culture medium.
DISCUSSION
Previous studies on the ela¢n promoter in other cell types have
provisionally assigned the transcription start site on the basis of
the location of a putative TATA box at position ^94/^89 (all posi-
tions mentioned here are relative to the translation start site). Here
we have experimentally determined the transcription start site of
the ela¢n gene using two independent methods.We found that
transcription starts at a point di¡erent than was expected, result-
ing in an mRNAwith an unusually short 50 -UTR. This would
imply that the presumed TATA box is located further away from
the transcription start site than the canonical 25 bp. In view of
these results we suggest that the TATA box sequence at position
94/89 could be nonfunctional. Alternatively, at position 48/
42 we found a sequenceTAAAGAT, that is, with respect to spa-
cing, more likely to serve as the actual TATA box. The fact that
this proposed TATA box deviates from the consensus sequence for
TATA boxes (TATA[A/T]A[A/T]) might explain the existence of
multiple transcription start points (Smale and Baltimore, 1989).
A previous study by others, using ela¢n promoter constructs in
a mammary epithelial cell line, has suggested the importance of
an alkaline phosphatase-1 site at ^545/^539 (Zhang et al, 1997).
This was, however, not evident in our study as we found no de-
crease of promoter activity upon deletion of a sequence region
Figure 5. E¡ect of TNFa and RA on the mRNA expression of ela-
¢n and ela¢n-EGFP in cell cultures of stably transfected HaCaTcell
lines. Both unstipulated and TNFa-stimulated (25 ng/ml) cultures of the
0.8 kb-and the 4 kb-ela¢nprom clone were treated with indicated amounts
of RA for 72 h. Northern blot analysis was performed on total RNA iso-
lated from these cultures. Samples were hybridized using a probe directed
against ela¢n.
Figure 6. RA counteracts the TNFa-dependent induction of endo-
genous ela¢n but not the TNFa-dependent induction of the ela¢n-
EGFP fusion protein. (A) Both unstimulated and TNFa-stimulated cul-
tures of the 0.8 kb-ela¢nprom clone, were treated with indicated amounts
of RA for 72 h. Levels of endogenous ela¢n were determined from cell
culture medium using a sandwich-type ELISA speci¢c for ela¢n.Values re-
present the mean 7 SD (n¼ 4). npo0.005 versus control values of unsti-
mulated samples, and npo0.005 versus control values of TNFa stimulated
samples, by one-way analysis of variance with Duncan’s multiple compar-
ison test. (B) Both unstimulated and TNFa-stimulated cultures of the 0.8
kb-ela¢nprom clone and untransfected HaCaTwere treated with indicated
amounts of RA for 72 h. A sandwich-type ELISA speci¢c for ela¢n-EGFP
was used to determine levels of fusion protein from cell culture medium.
Assay background values were obtained from culture supernatant of either
unstimulated or TNFa-stimulated untransfected HaCaT. Levels of ela¢n-
EGFP from samples of the 0.8 kb-ela¢nprom clone were expressed relative
to these background values. Values represent the mean 7 SD (n¼ 4). An
e¡ect of RA on levels of ela¢n-EGFP could not be demonstrated (one-way
analysis of variance).
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from 1021 to 440.We found a signi¢cant decrease of promoter
activity upon deletion of the sequence from 440 to 290. This
region contains three NF-IL6 consensus binding sequences; how-
ever, the importance of this region has not been demonstrated in
promoter constructs described by others using epithelial cell lines
from other organs. This indicates that expression regulation of
plasmid-encoded reporter constructs can vary between cell types
from di¡erent tissues, or between primary cells (used by us) and
cell lines. Further reduction of the ela¢n promoter region be-
tween 170 and 130 virtually abolished all residual promoter
activity. In this region of the ela¢n promoter a consensus se-
quence for the transcription factor NFkB is present at 163 to
154. The importance of this site has been established before in
transient transfection assays in a lung epithelial cell line (Bingle
et al, 2001).We have not further investigated the functional signif-
icance of the NFkB site by internal mutation of this site in a
larger fragment.
Our transfection experiments with ela¢n promoter constructs
in keratinocytes showed a discrepancy between the expression of
these clones and the endogenous gene.Whereas the endogenous
ela¢n gene is induced in cultured keratinocytes by the addition of
5% FBS, the reporter gene constructs are active under all culture
conditions. We therefore surmised that the reporter constructs
consisting of naked plasmid DNAwere not suitable to study ela-
¢n gene regulation in further detail. Using stably transfected re-
porter constructs in the HaCaT keratinocyte cell line we could
indeed demonstrate that both a 0.8 kb and a 4 kb promoter frag-
ment contained enough information for TNF-a induction of the
transgene. The discrepancy between transcription of naked DNA
from promoter constructs and the nuclear DNA wrapped in a
highly organized chromatin structure has been observed fre-
quently (DiSepio et al, 1995; Felsenfeld et al, 1996). Therefore,
also other processes such as silencing elements not present in
the transfection clones, mRNA stability or higher order
chromatin structure might be involved in transcription regulation
of the endogenous ela¢n gene. In that respect p38 kinase
activity, which is crucial for ela¢n expression in vitro, could
play a part. Recently it has been described in a number of
papers that mRNA can be stabilized through mitogen-activated
protein kinase mediated processes, including p38 (Chen et al,
1998; Dean et al, 1999), upon cellular stress. With respect to
mRNA stability the unusual length of the 50 -untranslated region
of the ela¢n mRNA could be of some signi¢cance, although it
has been described that the 30 -UTR rather than the 50 -UTR is
important for mRNA stability (Wickens et al, 1997; Day and
Tuite, 1998).
With respect to basal transcription levels of endogenous ela¢n
(Fig 3), it should be noted that these levels are not identical be-
tween stably transfected clones tested. This can be explained by
the fact that the parental HaCaT cell line is indeed a line and not
a clone. Originally, this line was karyotyped as being aneuploid
(Boukamp et al, 1988).We have con¢rmed this aneuploidity and
have also found the HaCaTcell line to be heterogeneous with re-
spect to chromosome number. It is from this cell line that we ob-
tained single cells of which clones were derived. These now can
have distinct transcription levels of endogenous ela¢n because
they originate from di¡erent cells.
The rationale to study regulation of ela¢n expression was
based on the assumption that ela¢n is a model gene for the
activated keratinocyte pathway. We reasoned that elucidation of
ela¢n induction, regulation of its expression, and pharmacologic
manipulation could lead to further insight into the various
epidermal di¡erentiation pathways or could even shed light on
keratinocyte abnormalities, e.g., as observed in psoriasis. Having
established that chromosomal integration of the ela¢n promoter/
reporter construct was necessary for proper regulation, we
asked if these cell lines could be used to study the e¡ect of
pharmacologic manipulation of ela¢n expression. Unfortunately,
we found that the expression of the stably transfected reporter
constructs carrying a 0.8 kb or a 4 kb ela¢n promoter fragment
are not subjected to RA-induced suppression as is the case for
the endogenous gene. This strongly suggests that additional cis-
acting sequences or a correct genomic environment is required.
In conclusion, the results presented in this study show the com-
plex regulation of the ela¢n gene and provide the basis for
further studies needed to unravel this gene’s molecular regulation
mechanism.
Part of this work was supported by a grant from Health Research and Development
Council (ZON 9802.037.0), the Netherlands.
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